{
    "root": "9c828bee-09d3-4021-99e7-e5fd3e83741c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "valsartan"
    },
    "value": "20250207",
    "ingredients": [
        {
            "name": "Valsartan",
            "code": "80M03YXJ7I"
        },
        {
            "name": "Microcrystalline Cellulose",
            "code": "OP1R32D61U"
        },
        {
            "name": "Crospovidone",
            "code": "2S7830E561"
        },
        {
            "name": "Silicon Dioxide",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "Anhydrous Lactose",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "Magnesium Stearate",
            "code": "70097M6I30"
        },
        {
            "name": "Polyethylene Glycol 8000",
            "code": "Q662QK8M3B"
        },
        {
            "name": "Hypromellose, Unspecified",
            "code": "3NXW29V3WO"
        },
        {
            "name": "Titanium Dioxide",
            "code": "15FIX9V2JP"
        },
        {
            "name": "Ferric Oxide Yellow",
            "code": "EX438O2MRT"
        },
        {
            "name": "Ferric Oxide Red",
            "code": "1K09F3G675"
        }
    ],
    "indications": "Valsartan tablets are angiotensin II receptor blocker (ARB) indicated for: Hypertension, to lower blood pressure in adults and children 6 years and older. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions (1.1) Heart failure (NYHA class II-IV), to reduce hospitalization for heart failure in adults (1.2) Post-myocardial infarction, for the reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction in adults( 1.3 )",
    "contraindications": "Indication Starting Dose Dose Range* Hypertension Adults (2.2 ) 80-160 mg once daily 80-320mg once daily 6-16 years ( 2. 3) 1 mg/kg once daily (Up to 40 mg daily) 1-4 mg/kg once daily  Up to 160 mg daily Heart Failure ( 2.4) 40 mg twice daily 40-160 mg twice daily Post-Myocardial Infarction ( 2.5 ) 20 mg twice daily 20-160 mg twice daily *As tolerated by patient",
    "warningsAndPrecautions": "Valsartan Tablets, USP are available as follows:   \n                      40 mg tablets are yellow colored, capsule shaped, biconvex, film coated tablets, with a scoreline on one side, debossed with 'C' on one side of scoreline and 'I' on the other side of scoreline and plain on the other side. \n                                  Bottle of 30’s (child-resistant closure)                      NDC 59746-360-30              Bottle of 90’s (child-resistant closure)                      NDC 59746-360-90              Bottle of 500’s                                                       NDC 59746-360-05              Blister Carton of 100’s (10 x 10’s)                            NDC 59746-360-03   \n                      80 mg tablets are peach colored, round, biconvex, film coated tablets, debossed with 'C3' on one side and 'C' on other side.              Bottle of 30’s (child-resistant closure)                      NDC 59746-361-30              Bottle of 90’s (child-resistant closure)                      NDC 59746-361-90              Bottle of 500’s                                                       NDC 59746-361-05              Blister Carton of 100’s (10 x 10’s)                           NDC 59746-361-03   \n                      160 mg tablets are yellow colored, oval shaped, biconvex, film coated tablets, debossed with 'C4' on one side and 'C' on other side.               Bottle of 30’s (child-resistant closure)                      NDC 59746-362-30               Bottle of 90’s (child-resistant closure)                      NDC 59746-362-90               Bottle of 500’s                                                       NDC 59746-362-05               Blister Carton of 100’s (10 x 10’s)                           NDC 59746-362-03   \n                      320 mg tablets are yellow colored, oval shaped, biconvex, film coated tablets, debossed with 'C5' on one side and 'C' on other side.                Bottle of 30’s (child-resistant closure)                     NDC 59746-363-30              Bottle of 90’s (child-resistant closure)                     NDC 59746-363-90              Bottle of 400’s                                                       NDC 59746-363-67              Blister Carton of 30’s (3 x 10’s)                               NDC 59746-363-32   \n                      Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F and  86°F) [See USP Controlled Room Temperature].   \n                      Protect from moisture.    \n                      Dispense in tight container (USP).",
    "adverseReactions": "Do not use in patients with known hypersensitivity to any component. Do not coadminister aliskiren with valsartan in patients with diabetes [see Drug Interactions (7)]."
}